Clinical Trials Arena January 26, 2023
Urtė Fultinavičiūtė

From bypassing animal testing to forecasting outcomes, we review some of the latest use cases of predictive analytics in drug development.

Scientific and technological advancements continue to shake the conservative nature of the pharmaceutical industry. Newer technologies like artificial intelligence (AI) have the potential to improve patient identification, adherence and retention, and the development of digital biomarkers. Today, complementary approaches that have been around for some time, such as predictive analytics, continue to solidify and expand their uses in drug development and clinical trial design.

The concept of predictive analytics is fairly simple – it is the ability to use data, algorithms, and visualisations to forecast a certain outcome or event that may or may not...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Analytics, Biotechnology, Pharma, Pharma / Biotech, Technology
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Cerevel Parkinson’s data adds lustre to AbbVie acquisition
Roche Drug Scores Label Expansion for Earlier Use in Lung Cancer
Pharma Pulse 4/19/24: The Health and Healthcare of Gen-Z, Long-Acting Drugs May Revolutionize HIV Prevention/Treatment & more
Recursion, Canaan, Metsera and more—Chutes & Ladders

Share This Article